![](/img/cover-not-exists.png)
Adding bevacizumab to single-agent chemotherapy for the treatment of platinum-resistant recurrent ovarian cancer: A cost-effectiveness analysis of the AURELIA trial
Wysham, W.Z., Schaffer, E.M., Coles, T.M., Roque, D.R., Wheeler, S.B., Kim, K.H.Volume:
141
Language:
english
Journal:
Gynecologic Oncology
DOI:
10.1016/j.ygyno.2016.04.116
Date:
June, 2016
File:
PDF, 52 KB
english, 2016